Levonantradol

Synthetic cannabinoid used for its antiemetic and analgesic properties

Levonantradol is a synthetic cannabinoid that has been studied for its potential use in treating nausea and pain. It is a derivative of dronabinol, which is the active component of tetrahydrocannabinol (THC), the primary psychoactive constituent of cannabis. Levonantradol is not currently approved for medical use but has been the subject of research due to its pharmacological properties.

Pharmacology

Levonantradol acts as an agonist at the cannabinoid receptors in the body, primarily the CB1 and CB2 receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including pain perception, appetite, and immune response.

Mechanism of Action

Levonantradol binds to cannabinoid receptors, mimicking the effects of naturally occurring cannabinoids. This binding leads to the modulation of neurotransmitter release, resulting in its analgesic and antiemetic effects. The activation of CB1 receptors in the central nervous system is primarily responsible for its ability to reduce pain and nausea.

Clinical Uses

Although not approved for clinical use, levonantradol has been investigated in clinical trials for its potential to treat:

• Nausea and vomiting: Particularly in patients undergoing chemotherapy for cancer.
• Pain management: Including neuropathic pain and pain associated with multiple sclerosis.

Side Effects

The side effects of levonantradol are similar to those of other cannabinoids and may include:

• Drowsiness
• Dizziness
• Dry mouth
• Euphoria
• Tachycardia

Research

Research on levonantradol has primarily focused on its potential as an antiemetic and analgesic. Studies have shown that it can be effective in reducing nausea and pain, but its psychoactive effects and potential for abuse have limited its development as a therapeutic agent.

Legal Status

Levonantradol is not approved for medical use in any country and is classified as a Schedule I controlled substance in the United States, indicating a high potential for abuse and no accepted medical use.

Related pages

• Cannabinoid receptor
• Endocannabinoid system
• Dronabinol
• Tetrahydrocannabinol

Levonantradol

• 

  Levonantradol

• 

  Nantradol synthesis

• 

  Nantradols structure